Read by QxMD icon Read

autoimmune hepatitis

shared collection
7 papers 0 to 25 followers
By Jorge Segadas-Soares Hepatoly professor
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani
INTRODUCTION: Autoimmune hepatitis (AIH) is a severe life-threatening hepatopathy of unknown etiology, affecting both pediatric and adult populations, and characterised by inflammatory liver histology, circulating non-organ-specific autoantibodies, and hypergammaglobulinaemia. AIH is a very heterogeneous disease with a variety of clinical presentations, ranging from asymptomatic liver test abnormalities to acute severe hepatitis or even acute liver failure. It responds very well to immunosuppressive treatment with prednisolone with or without azathioprine...
June 3, 2016: Expert Review of Gastroenterology & Hepatology
V Selvarajah, A J Montano-Loza, A J Czaja
BACKGROUND: Corticosteroid treatment for autoimmune hepatitis has been shown by randomised controlled clinical trials to ameliorate symptoms, normalise liver tests, improve histological findings and extend survival. Nevertheless, suboptimal responses to corticosteroid treatment still occur. AIM: To describe the current definitions, frequencies, clinical relevance and treatment options for suboptimal responses, and to discuss alternative medications that have been used off-label for these occurrences...
October 2012: Alimentary Pharmacology & Therapeutics
A J Czaja
BACKGROUND: Consensus guidelines aid in the diagnosis and management of autoimmune hepatitis, but they are frequently based on low-quality clinical evidence, conflicting experiences and divergent opinions. Recommendations may be weak, discrepant or non-existent at critical decision points. AIMS: To identify the decision points where guidelines are weak or non-existent and review the evidence essential in the decision process. METHODS: Full-text articles published in English using the keyword 'autoimmune hepatitis' were identified by PubMed from 1972 to 2013...
August 2013: Alimentary Pharmacology & Therapeutics
Rachel H Westbrook, Andrew D Yeoman, Stephen Kriese, Michael A Heneghan
INTRODUCTION: Optimal management during pregnancy of patients with autoimmune hepatitis (AIH) remains undefined. We therefore reviewed all patients with AIH who reported pregnancy at our centre to identify any pre-conception factors that might predict adverse outcomes. RESULTS: There were 81 pregnancies in 53 women. Median age at conception was 26 years (range 16-42); with 41% of pregnancies occurring in the context of cirrhosis. At conception, 61 patients (75%) were on therapy for AIH...
May 2012: Journal of Autoimmunity
Christina Weiler-Normann, Christoph Schramm, Alexander Quaas, Christiane Wiegard, Claudia Glaubke, Nadine Pannicke, Sina Möller, Ansgar W Lohse
BACKGROUND & AIMS: Autoimmune hepatitis is a chronic inflammatory liver disease that leads to liver cirrhosis and corresponding complications, if left untreated. Current standard treatment with azathioprine and prednisolone induces remission in the vast majority of patients. However, for those patients not responding to standard treatment or not tolerating these drugs, few alternatives can be used and their effectiveness might be limited. We sought to analyze the safety and efficacy of off-label treatment with infliximab in a cohort of eleven patients with difficult-to-treat autoimmune hepatitis...
March 2013: Journal of Hepatology
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani
The accurate diagnosis and classification of autoimmune hepatitis (AIH) rely upon the detection of characteristic autoantibodies. Positivity for anti-nuclear (ANA) and/or anti-smooth muscle (SMA) autoantibodies defines AIH type 1 (AIH-1), whereas anti-liver kidney microsomal type 1 (anti-LKM1) and/or anti-liver cytosol type 1 (anti-LC1) define AIH type 2 (AIH-2). ANA and SMA, and less commonly anti-LKM1, have also been detected in de-novo autoimmune hepatitis developing after liver transplantation, a condition that may affect patients transplanted for non-autoimmune liver disease...
October 2013: Journal of Autoimmunity
Nicole M F van Gerven, Bart J Verwer, Birgit I Witte, Bart van Hoek, Minneke J Coenraad, Karel J van Erpecum, Ulrich Beuers, Henk R van Buuren, Rob A de Man, Joost P H Drenth, Jannie W den Ouden, Robert C Verdonk, Ger H Koek, Johannes T Brouwer, Maureen M J Guichelaar, Chris J J Mulder, Karin M J van Nieuwkerk, Gerd Bouma
BACKGROUND & AIMS: Current treatment strategies in autoimmune hepatitis (AIH) include long-term treatment with corticosteroids and/or azathioprine. Here we determined the risk of relapse after drug withdrawal in patients in long-term remission and factors associated with such a relapse. METHODS: A total of 131 patients (out of a cohort including 844 patients) from 7 academic and 14 regional centres in the Netherlands were identified in whom treatment was tapered after at least 2 years of clinical and biochemical remission...
January 2013: Journal of Hepatology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"